Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience.
Apple and Samsung may not need glucose-sensing smartwatches to compete in health AI. The next race is turning CGM data into useful advice.
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
Real-time blood glucose monitoring is claimed to help endurance athletes better understand their carbohydrate requirements and tailor their nutrition accordingly to optimise performance. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results